Annual Accounts Payable
$16.33 M
-$5.76 M-26.08%
May 26, 2024
Summary
- As of February 7, 2025, LFCR annual accounts payable is $16.33 million, with the most recent change of -$5.76 million (-26.08%) on May 26, 2024.
- During the last 3 years, LFCR annual accounts payable has risen by +$36.00 thousand (+0.22%).
- LFCR annual accounts payable is now -69.74% below its all-time high of $53.97 million, reached on May 1, 2019.
Performance
LFCR Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$14.97 M
-$3.04 M-16.90%
November 24, 2024
Summary
- As of February 7, 2025, LFCR quarterly accounts payable is $14.97 million, with the most recent change of -$3.04 million (-16.90%) on November 24, 2024.
- Over the past year, LFCR quarterly accounts payable has dropped by -$718.00 thousand (-4.58%).
- LFCR quarterly accounts payable is now -76.49% below its all-time high of $63.66 million, reached on February 1, 2020.
Performance
LFCR Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
LFCR Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.1% | -4.6% |
| 3 y3 years | +0.2% | -4.6% |
| 5 y5 years | -69.7% | -68.3% |
LFCR Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.1% | +26.1% | -46.5% | +15.6% |
| 5 y | 5-year | -69.7% | +26.1% | -76.5% | +15.6% |
| alltime | all time | -69.7% | +3166.8% | -76.5% | +4889.0% |
Lifecore Biomedical Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2024 | - | $14.97 M(-16.9%) |
| Aug 2024 | - | $18.01 M(+10.3%) |
| May 2024 | $16.33 M(-26.1%) | $16.33 M(+4.1%) |
| Feb 2024 | - | $15.69 M(-17.5%) |
| Nov 2023 | - | $19.02 M(+21.2%) |
| Aug 2023 | - | $15.69 M(-29.0%) |
| May 2023 | $22.10 M(+70.6%) | $22.10 M(+49.7%) |
| Feb 2023 | - | $14.76 M(-47.2%) |
| Nov 2022 | - | $27.97 M(+70.9%) |
| Aug 2022 | - | $16.37 M(+26.4%) |
| May 2022 | $12.95 M(-20.5%) | $12.95 M(-35.3%) |
| Feb 2022 | - | $20.01 M(-66.1%) |
| Nov 2021 | - | $59.10 M(+27.5%) |
| Aug 2021 | - | $46.35 M(+184.4%) |
| May 2021 | $16.30 M(-68.4%) | - |
| May 2021 | - | $16.30 M(-71.1%) |
| Feb 2021 | - | $56.32 M(-7.5%) |
| Nov 2020 | - | $60.89 M(+20.1%) |
| Aug 2020 | - | $50.72 M(-1.8%) |
| May 2020 | $51.65 M(-4.3%) | $51.65 M(-18.9%) |
| Feb 2020 | - | $63.66 M(+35.0%) |
| Nov 2019 | - | $47.15 M(+2.1%) |
| Aug 2019 | - | $46.16 M(-14.5%) |
| May 2019 | $53.97 M(+55.7%) | $53.97 M(+16.2%) |
| Feb 2019 | - | $46.43 M(+46.4%) |
| Nov 2018 | - | $31.72 M(+17.4%) |
| Aug 2018 | - | $27.03 M(-22.0%) |
| May 2018 | $34.67 M(+41.3%) | $34.67 M(-1.6%) |
| Feb 2018 | - | $35.24 M(-6.0%) |
| Nov 2017 | - | $37.48 M(+39.1%) |
| Aug 2017 | - | $26.95 M(+9.9%) |
| May 2017 | $24.53 M(-20.6%) | $24.53 M(-1.0%) |
| Feb 2017 | - | $24.76 M(-4.4%) |
| Nov 2016 | - | $25.91 M(-18.0%) |
| Aug 2016 | - | $31.61 M(+2.3%) |
| May 2016 | $30.90 M(-11.7%) | $30.90 M(+23.2%) |
| Feb 2016 | - | $25.09 M(-32.0%) |
| Nov 2015 | - | $36.92 M(+15.6%) |
| Aug 2015 | - | $31.95 M(-8.7%) |
| May 2015 | $35.01 M(+9.0%) | $35.01 M(+23.7%) |
| Feb 2015 | - | $28.31 M(-28.4%) |
| Nov 2014 | - | $39.52 M(+5.7%) |
| Aug 2014 | - | $37.38 M(+16.4%) |
| May 2014 | $32.12 M(-0.4%) | $32.12 M(+8.0%) |
| Feb 2014 | - | $29.73 M(-14.5%) |
| Nov 2013 | - | $34.76 M(+18.3%) |
| Aug 2013 | - | $29.38 M(-8.9%) |
| May 2013 | $32.26 M(+37.7%) | $32.26 M(+15.5%) |
| Feb 2013 | - | $27.93 M(+5.9%) |
| Nov 2012 | - | $26.37 M(-3.3%) |
| Aug 2012 | - | $27.26 M(+16.4%) |
| May 2012 | $23.42 M(+37.4%) | $23.42 M(+59.7%) |
| Feb 2012 | - | $14.67 M(-23.7%) |
| Nov 2011 | - | $19.22 M(+3.7%) |
| Aug 2011 | - | $18.53 M(+8.7%) |
| May 2011 | $17.05 M | $17.05 M(+12.6%) |
| Feb 2011 | - | $15.14 M(-20.5%) |
| Nov 2010 | - | $19.05 M(+4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Aug 2010 | - | $18.25 M(+27.2%) |
| May 2010 | $14.35 M(+15.5%) | $14.35 M(+26.3%) |
| Feb 2010 | - | $11.36 M(-28.1%) |
| Nov 2009 | - | $15.81 M(-20.9%) |
| Aug 2009 | - | $20.00 M(+60.9%) |
| May 2009 | $12.43 M(-34.5%) | $12.43 M(+22.7%) |
| Feb 2009 | - | $10.13 M(-38.3%) |
| Nov 2008 | - | $16.42 M(-10.9%) |
| Aug 2008 | - | $18.44 M(-2.9%) |
| May 2008 | $18.99 M(+36.8%) | $18.99 M(+63.4%) |
| Feb 2008 | - | $11.62 M(-17.8%) |
| Nov 2007 | - | $14.15 M(-15.4%) |
| Aug 2007 | - | $16.73 M(+20.5%) |
| May 2007 | $13.88 M(+7.0%) | $13.88 M(+33.9%) |
| Feb 2007 | - | $10.36 M(-21.2%) |
| Nov 2006 | - | $13.15 M(-42.6%) |
| Aug 2006 | - | $22.90 M(+76.5%) |
| May 2006 | $12.98 M(-29.1%) | $12.98 M(-14.6%) |
| Feb 2006 | - | $15.19 M(-20.1%) |
| Nov 2005 | - | $19.00 M(+2.6%) |
| Aug 2005 | - | $18.53 M(+1.2%) |
| May 2005 | $18.31 M(+18.9%) | $18.31 M(+63.1%) |
| Feb 2005 | - | $11.22 M(-32.6%) |
| Nov 2004 | - | $16.66 M(+3.5%) |
| Aug 2004 | - | $16.10 M(+4.6%) |
| May 2004 | $15.39 M(+10.4%) | $15.39 M(+31.3%) |
| Feb 2004 | - | $11.72 M(-1.1%) |
| Nov 2003 | - | $11.86 M(-13.7%) |
| Aug 2003 | - | $13.75 M(+3.5%) |
| May 2003 | $13.94 M(+21.1%) | - |
| Apr 2003 | - | $13.28 M(+28.2%) |
| Jan 2003 | - | $10.36 M(-10.0%) |
| Oct 2002 | $11.51 M(-33.2%) | $11.51 M(-25.1%) |
| Jul 2002 | - | $15.36 M(+5.7%) |
| Apr 2002 | - | $14.53 M(-21.3%) |
| Jan 2002 | - | $18.47 M(+7.1%) |
| Oct 2001 | $17.24 M(-6.8%) | $17.24 M(+0.3%) |
| Jul 2001 | - | $17.19 M(-21.9%) |
| Apr 2001 | - | $22.01 M(+18.2%) |
| Jan 2001 | - | $18.63 M(+0.7%) |
| Oct 2000 | $18.50 M(+988.3%) | $18.50 M(-14.9%) |
| Jul 2000 | - | $21.74 M(-7.6%) |
| Apr 2000 | - | $23.52 M(-3.2%) |
| Jan 2000 | - | $24.30 M(+1329.4%) |
| Oct 1999 | $1.70 M(+21.4%) | $1.70 M(+30.8%) |
| Jul 1999 | - | $1.30 M(-7.1%) |
| Apr 1999 | - | $1.40 M(+16.7%) |
| Jan 1999 | - | $1.20 M(-14.3%) |
| Oct 1998 | $1.40 M(+133.3%) | $1.40 M(+55.6%) |
| Jul 1998 | - | $900.00 K(+12.5%) |
| Apr 1998 | - | $800.00 K(-38.5%) |
| Jan 1998 | - | $1.30 M(+116.7%) |
| Oct 1997 | $600.00 K(+20.0%) | $600.00 K(-45.5%) |
| Jul 1997 | - | $1.10 M(-21.4%) |
| Apr 1997 | - | $1.40 M(+366.7%) |
| Jan 1997 | - | $300.00 K(-40.0%) |
| Oct 1996 | $500.00 K | $500.00 K(+66.7%) |
| Jul 1996 | - | $300.00 K(0.0%) |
| Apr 1996 | - | $300.00 K |
FAQ
- What is Lifecore Biomedical annual accounts payable?
- What is the all time high annual accounts payable for Lifecore Biomedical?
- What is Lifecore Biomedical annual accounts payable year-on-year change?
- What is Lifecore Biomedical quarterly accounts payable?
- What is the all time high quarterly accounts payable for Lifecore Biomedical?
- What is Lifecore Biomedical quarterly accounts payable year-on-year change?
What is Lifecore Biomedical annual accounts payable?
The current annual accounts payable of LFCR is $16.33 M
What is the all time high annual accounts payable for Lifecore Biomedical?
Lifecore Biomedical all-time high annual accounts payable is $53.97 M
What is Lifecore Biomedical annual accounts payable year-on-year change?
Over the past year, LFCR annual accounts payable has changed by -$5.76 M (-26.08%)
What is Lifecore Biomedical quarterly accounts payable?
The current quarterly accounts payable of LFCR is $14.97 M
What is the all time high quarterly accounts payable for Lifecore Biomedical?
Lifecore Biomedical all-time high quarterly accounts payable is $63.66 M
What is Lifecore Biomedical quarterly accounts payable year-on-year change?
Over the past year, LFCR quarterly accounts payable has changed by -$718.00 K (-4.58%)